SCWorx Corp. (WORX)
NASDAQ: WORX · Real-Time Price · USD
0.5700
-0.0800 (-12.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed
SCWorx Revenue
In the year 2024, SCWorx had annual revenue of $2.99M, down -21.43%. SCWorx had revenue of $675.75K in the quarter ending December 31, 2024, a decrease of -25.77%.
Revenue (ttm)
$2.99M
Revenue Growth
-21.43%
P/S Ratio
0.28
Revenue / Employee
$427,086
Employees
7
Market Cap
1.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.99M | -815.34K | -21.43% |
| Dec 31, 2023 | 3.80M | -233.25K | -5.78% |
| Dec 31, 2022 | 4.04M | -594.34K | -12.83% |
| Dec 31, 2021 | 4.63M | -580.59K | -11.14% |
| Dec 31, 2020 | 5.21M | -335.00K | -6.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
WORX News
- 4 months ago - SCWorx Reminds Stockholders of Annual Meeting - GlobeNewsWire
- 5 months ago - SCWorx Announces Compliance with Nasdaq's Periodic Reporting Listing Standard - GlobeNewsWire
- 5 months ago - SCWorx Announces Completion of Equity Financing with Institutional Investors - GlobeNewsWire
- 8 months ago - SCWorx Corp. Receives Notice of Non-Compliance from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended June 30, 2024 - GlobeNewsWire
- 1 year ago - SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended March 31, 2024 - GlobeNewsWire
- 1 year ago - SCWorx Corp. Receives Expected Notice from NASDAQ Stock Market Pertaining to its 10-K of December 31, 2023 - GlobeNewsWire
- 1 year ago - SCWorx Signs Letter of Intent to Acquire an Environmental Services Company - GlobeNewsWire
- 1 year ago - SCWorx Shareholders Overwhelmingly Approve Reverse Stock Split at Annual Meeting - GlobeNewsWire